TAN LEE SU-LENG (CEO) received a stock award from BIONEXUS GENE LAB CORP
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/14/2026ACC: 0001520138-26-000349
DirectorOfficer· CEO
Since Aug 2023
+338.71K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
338.71K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+338.71K
Price / share
—
Trade value
—
% of position
New position
8/13/2026
0.00→338.71K
Total
Net shares
+338.71K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 8/13/2026 | A · Award | +338.71K | — | — | New position | 0.00 | 338.71K |
| Total | +338.71K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported